-
FDA to allow GSK’s Avandia, with restrictions
SILVER SPRING, Md. The Food and Drug Administration has moved to significantly restrict access to a controversial diabetes drug made by GlaxoSmithKline.
The agency said Thursday that it would restrict access to the Type 2 diabetes medication Avandia (rosiglitazone) in response to clinical study data suggesting that its use can increase the risk of heart attacks and strokes.
-
New Health Reform Report website provides 'real facts, trusted analysis' about healthcare law
WASHINGTON Newt Gingrich, former House speaker and founder of the Center for Health Transformation, unveiled a new website on Wednesday -- HealthReformReport.com -- dedicated to providing “real facts, trusted analysis” with news about how the new federal healthcare law impacts individuals, doctors, businesses, hospitals, insurers and others.